State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian's CEO
Source: Cell & Gene
Dr. Murat Kalayoglu, CEO at Cartesian Therapeutics, details the cell and gene therapy sector's advancements in RNA cell therapy and the why behind the company's decision to build its own wholly-owned GMP manufacturing facility.
This website uses cookies to ensure you get the best experience on our website. Learn more